Immunopathology and Immunotherapy of Lymphoblastic Leukaemia

Feb 18, 2017 by in ONCOLOGY Comments Off on Immunopathology and Immunotherapy of Lymphoblastic Leukaemia

Stage Immune phenotype Target Early precursor HLA-DR, TdT, cCD22, CD79a, CD19 CD19 Blinatumomab Intermediate precursor (common) HLA-DR, TdT, cCD22, CD79a, CD19, CD10, CD20 (variable) CD19 Blinatumomab CD20 Rituximab, ofatumumab Late…

read more
Get Clinical Tree app for offline access